SSSI for dapsone tablets


A shortage of 25mg tablets prompted the substitution guidance   The Therapeutic Goods Administration (TGA) has issued substitution advice due to the short supply of dapsone 25mg tablets. Under the Serious Scarcity Substitution Instrument (SSSI), pharmacists will be able to dispense substitutional medicine (in this case dapsone 50mg) in place of the prescribed medicine without

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Crime crackdown welcomed
This is the most recent story.